Aim: To study prescribing pattern, comorbidities, and cost analysis in elderly hospitalized patients. Materials and Methods: A prospective, observational study was conducted to assess the prescribing pattern, drug utilization, and cost analysis in elderly patients at a tertiary care hospital in Pune. Data of 120 patients were used to carry out the analysis. Result: A total of 120 elderly inpatients were included in the study. Of these 120 patients, 62 were male and 58 were female; among them, maximum number of patients belong to 60-74 years age group. Common comorbidities found were anemia, lower respiratory tract infections (LRTI), urinary tract infection, hypertension, diabetes mellitus, etc. Mostly hospitalized patients were hypertensive (27.5%), diabetic (18.33%), and anemic (15.83%) followed by respiratory tract infections such as pulmonary Koch's, pneumonia, and LRTI. Two comorbid conditions were found in 33.33% of patients followed by 25% with one comorbid condition and 24.16% had three comorbid conditions; on an average, three comorbidities were found in a total number of patients. Major classes of drugs prescribed for treatment were cardiovascular drugs (22.60%), antibiotic (20.13%), antiplatelet (7.26%), and antidiabetic drugs (6.43%). The average cost per patient was calculated 5016.48 international normalized ratio, which includes physician, nursing, bed charges, and therapy cost. Conclusion: This study concludes that the prescribing pattern of elderly patients with age group 60-74 years were commonly prescribed for cardiovascular drugs and antibiotic, whereas this proportion was low compared to patients with age >74 years and prescribing pattern also resulted in financial burden on patients healthcare cost.
INTRODUCTION
Across the globe over the last few decades, there has been a remarkable increase in the proportion of the population which is elderly and this trend is set to continue. [1] The size of India's older adult population is greater than the total population of many developed and developing countries. According to World Health Statistics 2011, 83 million persons in India are 60 years of age and older, representing over 7% of the nation's total population. Over the next four decades, India's demographic structure is expected to shift dramatically from young to aging population resulting in 316 million elderly persons by 2050. [2] In India, elderly and their caregivers and healthcare providers passively accept ill-health as part of old age. In fact, healthcare providers often view elderly patients in a "negative and mechanistic fashion." Elderly persons in India often die from preventable conditions such as bronchitis, asthma, and pneumonia. With increasing age, the prevalence of many diseases will increase. Older people are often excluded in trials, hence we often have limited knowledge regarding efficacy of pharmacotherapy in the elderly. [2] In general, aging inherent variability in physiologic differences becomes accentuated. The effects of disease are often additive and accumulate with time. Age-related physiological changes affect pharmacokinetics and pharmacodynamics in elderly; it may be the reason for prolong treatment as compared to younger persons. [3] The important change affecting pharmacokinetic is decline ability to excrete drugs from body. It increases the risk of drug accumulation. Pharmacokinetics includes absorption, distribution, metabolism, and excretion processes. Decreased gastric pH from diminished hydrochloric acid production affects the absorption of the drug. Age-related circulatory changes, such as decreased vessel elasticity, prolong distribution of drugs to the appropriate organ. Chronic health issues affecting circulation such as peripheral vascular disease and atherosclerosis also impact drug distribution. With aging, liver mass, volume, and blood flow, as well as enzyme production, decrease. These changes all potentially slow drug metabolism. Slower metabolism gives longer availability of drug in body and toxicity risk. Drug excretion is significantly affected in older adults. The kidneys are the primary organ for excretion. Glomerular filtration rate, renal blood flow, and tubular filtration are factors decline with age. These changes allow drugs to remain in the body longer and increase the risk of toxicity. [4] Pharmacodynamical change affects homeostatic mechanism in elderly and sometimes it produces inappropriate response. These physiological changes in demography will of course have impact on healthcare since age is a risk factor for many diseases. Cardiovascular disease, diabetes, and anemia are some examples of diseases with increasing prevalence with age; hence, the number of patients with these conditions will also increase. [5] Multimorbidity often simply involves the co-occurrence of two or more diseases; the distribution, combination, and development of different diseases (clustering) need to be better understood, as well as the mechanisms leading to the co-occurrence of diseases and the natural history of multimorbidity. [6] The elderly population has a higher prevalence of chronic and multiple diseases. Therefore, physicians often must treat patients with multiple chronic diseases such as cardiovascular diseases, arthritis, diabetes, dementia, hypertension (HTN), and cancers. [7] Multiple disease and multimorbidity inevitably lead to use of multiple drugs, condition known as polypharmacy. [6] The elderly at specific dose may experience exposure that is different from younger adults; this interindividual variability affects the drug prescribing in elderly. [1] Prescribers should therefore always consider whether nonpharmacological treatment may be appropriate before prescribing additional drugs to elderly patients. [5] Geriatric patients represent 12% of population but receive 30% of all prescriptions. Two-thirds of the patients use one or more drugs daily; average use is 5-12 drugs daily, and <5% use no drugs. The route of administration plays an important role in absorption and distribution of drug over body. Changes of taste and smell of dosage form make it unpleasant, small size of pills also affect the adherence to treatment. Elderly may skip the medications because they are unable to manipulate small pills. [4] In the richest economies, medical advances have been accompanied by increased health care spending for the elderly population; these costs are increasing proportionally faster than the elderly segment of the population. [7] There is need to update the clinicians on the pharmacotherapy of the elderly patients; hence, this study aims to analyze prescribing pattern, comorbidities, and cost analysis in elderly hospitalized patients.
MATERIALS AND METHODS
A 6-month prospective study was conducted in an 850-bedded Tertiary Care Hospital, Pune, India. The study protocol was approved by the Institutional Ethical Committee. One hundred and twenty elderly (≥60 years) patients were included in the study. Surgical reference and accidental cases were excluded from the study.
The names of patients and prescribing doctors were kept confidential throughout the study. The data collected during study were analyzed according to disease condition, comorbidity, and drug utilization. Statistical analysis was carried out using descriptive statistics.
RESULT
Of 120 patients admitted in the hospital, 62 (51.66%) were male and 58 (48.33%) were female, as shown in Figure 1 .
We observed various comorbidities in the patients among which anemic were most common followed by the other comorbid conditions such as lower respiratory tract infections, urinary tract infection (UTI), cervical spondylosis, ischemic heart diseases (IHD), and HTN. The list also presents that 64 patients were admitted with comorbid conditions rather than main diagnosis [ Table 1 ].
The reason for hospital admission of these patients ranged from different diseases such as HTN 27.5%, diabetes mellitus (DM) 18.33%, anemia 15.83%, IHD 14.16%, UTI 6.66%, cervical spondylosis 6.66%, pulmonary Koch's 5.83%, COPD 5.0%, Parkinson's disease 3.33%, and pneumonia 2.5%. Major illness includes HTN, DM, anemia, and IHD. In this study, 33 patients were hypertensive, out of those 66.66% patients had history of HTN; etiology of HTN among those patients was chronic kidney disease or heart disease. DM was one of the chronic ailments observed in this study. Many patients were admitted for management of uncontrolled diabetes and also show diabetic nephropathy. Carcinoma and chronic kidney disease were main reasons for anemic condition in patients which was frequently observed comorbidity in this study. About 6% patients admitted for management of pulmonary Koch's, and reason for hospital admission was relapse of pulmonary Koch's developed due to the noncompliance [ Table 2 ].
A large number of patients (33.33%, n = 40) had two comorbid conditions; on the other hand, some patients (25% n = 30) had one comorbid condition. A few number of patients had five or more comorbid conditions. The average number of comorbidity in this study was three per individual patients.
More than one in four patients had at least one comorbid condition and among patients with comorbidity, one in three had multicomorbidity (range >2). In this study, multicomorbidity is equally prevalent in younger and older elderly (27.17%, 29.34%, 27.17% vs. 10.71%, 46.42%, 14.28%) [ Table 3 ]. During the whole study period, drug therapy prescribed to 120 inpatients was monitored.
Around 1506 drugs were utilized in 120 patients with an average of 12 drugs/patient. Out of them, 1185 drugs are prescribed to patients who belong to age group 60-74 years and 321 to patients who belong to age group >75 years of age.
Cumulative prescriptions for selected prescribed drugs relative to distribution are presented in Table 4 . Drug prescribing pattern among geriatric patients shows that cardiovascular drugs prescriptions with 22.60% followed by antihypersecretory 21.50%, antibiotic 20.13%, antiemetic 104 (14.24%), antihyperlipidemic 57 (7.80%), antiplatelets 53 (7.26%), and antidiabetic 47 (6.43%) were found to be most commonly involved class in the hospitalized geriatric patients.
According to this study, patients with age group 60-74 years were commonly prescribed for cardiovascular system (CVS) drugs (78.78%) and antibiotic (78.23%) as compared to patients with age >75 years 21.21% and 21.76%, respectively [ Table 5 ].
The six most commonly prescribed medicines are shown in Table 6 . Ceftriaxone (69) was most commonly prescribed drug followed by amlodipine (48), furosemide (41), atorvastatin (44), and least commonly prescribed azithromycin (14) and ciprofloxacin (9) .
In this study, out of 1506 drugs, oral dosages form are most commonly prescribed which include tablets (47.80%), capsules (3.32%), syrups (8.89%), followed by intramuscular and intravenous (30.14%), and least prescribed dosage form are nebulization (2%), topical agents (1.32%), and others include eye/ear drops (6.50%) [ Tables 7 and 8 ].
A description of therapy costs of the elderly patients is presented in Table 9 . Summarizing the five subcategories of therapy costs (international normalized ratio [INR] 601978.2) gives a cost/patient of 5016.48. Figure 2 shows the distribution of total costs per patient.
Our results show that included 120 patients spent 601978.2 INR in the various services; it is difficult to compare our results from previous studies.
DISCUSSION
Our study showed male to female ratio was high, and some western studies carried out by Michocki et al. [8] showed that the ratio of male to female is slightly higher showing IM: Intramuscular, IV: Intravenous more than 80% patients were over 60 years and the ratio of male to female were 56% and 44%, respectively, but was approximately similar to the other Indian studies carried out by Zaveri et al. [9] showing that male to female ratio were 53.07% and 46.93% of hospitalized patients. The average number of comorbidities observed in this study was three per individual patients. This is slightly similar to the Indian study Rima Shah, which revealed two comorbities in majority of patients. [10] The reason for hospital admission of these patients was found to be history of different diseases like HTN, DM, anemia, and IHD. These results are similar to study carried out by Rahmawati et al. that included HTN 43%, DM 26%, pneumonia 17%, and UTI 13%. [11] The average number of comorbidities observed in this study was three per individual patients. This is slightly similar to the Indian study by Gupta et al. [10] Drug prescribing pattern in this study showed that cardiovascular drugs prescriptions were high followed by antihypersecretory, antibiotic, antiemetic, antihyperlipidemic, antiplatelets, and antidiabetic were found to be most commonly involved class in the hospitalized geriatric patients. The result was similar the Indian studies conducted by Sekhar et al. [12] showing that CVS 19.8%, antibiotic 11.3%, antiplatelet 9.09%, and the study results were slightly differ with the study of Nascimento Yde et al., [13] showing that CVS 34.9%, antiplatelet 4.6%, and antidiabetic 6.2% in studies, respectively.
The six most commonly prescribed drugs were ceftriaxone, amlodipine, furosemide, atorvastatin, azithromycin, and ciprofloxacin, which are slightly similar to the study carried out by Koh et al. shows that amlodipine prescribed in 50% patients. [14] We observed 120 patients spent around 6 lakhs INR in the various services and average cost per patient was around 5000 INR, which shows that there is substantial financial burden on the patients as well as their caregivers.
CONCLUSION
The study concluded that male to female ratio was high in the geriatrics patients admitted in hospital and the reasons for hospital admission in geriatric patients were HTN, DM, IHD, anemia, UTI among which HTN being the highest followed by the latter. The study also concluded most of the patients were admitted with comorbid conditions rather than the main diagnosis and on an average three comorbid conditions were found in hospitalized patients. The prescribing pattern of this study concluded that elderly patients with age group 60-74 years were commonly prescribed for cardiovascular drugs and antibiotic whereas this proportion was low compared to patients with age >74 years and the prescribing pattern also resulted in financial burden on patients healthcare cost.
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